Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1959 2
1973 1
1974 1
1975 2
1976 5
1977 4
1978 9
1979 2
1980 4
1981 1
1982 2
1983 2
1985 1
1986 3
1987 2
1988 2
1989 1
1990 6
1991 3
1992 5
1993 6
1994 4
1995 3
1996 3
1997 1
1998 1
1999 2
2000 6
2001 3
2002 6
2003 11
2004 14
2005 6
2006 6
2007 16
2008 7
2009 21
2010 18
2011 28
2012 27
2013 26
2014 45
2015 44
2016 45
2017 32
2018 40
2019 51
2020 50
2021 58
2022 48
2023 54
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

690 results

Results by year

Filters applied: . Clear all
Page 1
Modelling Structural Elements and Functional Responses to Lymphatic-Delivered Cues in a Murine Lymph Node on a Chip.
Mazzaglia C, Munir H, Le IM, Gerigk M, Huang YYS, Shields JD. Mazzaglia C, et al. Among authors: shields jd. Adv Healthc Mater. 2024 Apr 16:e2303720. doi: 10.1002/adhm.202303720. Online ahead of print. Adv Healthc Mater. 2024. PMID: 38626388
Beyond immune responses, this model also enables interrogation of changes in stromal cells, thus permitting investigations of all LN cellular components in homeostasis and different disease settings, such as cancer. Here, we present how LN behavior can be influenced by mur …
Beyond immune responses, this model also enables interrogation of changes in stromal cells, thus permitting investigations of all LN cellula …
A glycolytic metabolite bypasses "two-hit" tumor suppression by BRCA2.
Kong LR, Gupta K, Wu AJ, Perera D, Ivanyi-Nagy R, Ahmed SM, Tan TZ, Tan SL, Fuddin A, Sundaramoorthy E, Goh GS, Wong RTX, Costa ASH, Oddy C, Wong H, Patro CPK, Kho YS, Huang XZ, Choo J, Shehata M, Lee SC, Goh BC, Frezza C, Pitt JJ, Venkitaraman AR. Kong LR, et al. Among authors: frezza c, venkitaraman ar. Cell. 2024 Apr 8:S0092-8674(24)00255-1. doi: 10.1016/j.cell.2024.03.006. Online ahead of print. Cell. 2024. PMID: 38608703 Free article.
Here, we report that the glycolytic metabolite methylglyoxal (MGO) transiently bypasses Knudson's paradigm by inactivating the breast cancer suppressor protein BRCA2 to elicit a cancer-associated, mutational single-base substitution (SBS) signature in nonmalignant m …
Here, we report that the glycolytic metabolite methylglyoxal (MGO) transiently bypasses Knudson's paradigm by inactivating the breast can …
Limited oxygen in standard cell culture alters metabolism and function of differentiated cells.
Tan J, Virtue S, Norris DM, Conway OJ, Yang M, Bidault G, Gribben C, Lugtu F, Kamzolas I, Krycer JR, Mills RJ, Liang L, Pereira C, Dale M, Shun-Shion AS, Baird HJ, Horscroft JA, Sowton AP, Ma M, Carobbio S, Petsalaki E, Murray AJ, Gershlick DC, Nathan JA, Hudson JE, Vallier L, Fisher-Wellman KH, Frezza C, Vidal-Puig A, Fazakerley DJ. Tan J, et al. Among authors: frezza c. EMBO J. 2024 Apr 5. doi: 10.1038/s44318-024-00084-7. Online ahead of print. EMBO J. 2024. PMID: 38580776 Free article.
A systematic review of circulating predictive and prognostic biomarkers to aid the personalised use of radiotherapy in the radical treatment of patients with oesophageal cancer.
McClurg DP, Sanghera C, Mukherjee S, Fitzgerald RC, Jones CM. McClurg DP, et al. Among authors: fitzgerald rc. Radiother Oncol. 2024 Mar 11;195:110224. doi: 10.1016/j.radonc.2024.110224. Online ahead of print. Radiother Oncol. 2024. PMID: 38479442 Free article. Review.
Medline, EMBASE, PubMed, Cochrane Library, CINAHL, Scopus and the Web of Science databases were searched for studies published between January 2005-February 2023 relating to circulating biomarkers evaluated in the context of neoadjuvant or definitive RT delivered for OAC/O …
Medline, EMBASE, PubMed, Cochrane Library, CINAHL, Scopus and the Web of Science databases were searched for studies published betwee …
Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and Human.
García-Sancha N, Corchado-Cobos R, Blanco-Gómez A, Cunillera Puértolas O, Marzo-Castillejo M, Castillo-Lluva S, Alonso-López D, De Las Rivas J, Pozo J, Orfao A, Valero-Juan L, Patino-Alonso C, Perera D, Venkitaraman AR, Mao JH, Chang H, Mendiburu-Eliçabe M, González-García P, Caleiras E, Peset I, Cenador MBG, García-Criado FJ, Pérez-Losada J. García-Sancha N, et al. Among authors: venkitaraman ar. Res Sq [Preprint]. 2024 Feb 5:rs.3.rs-3854490. doi: 10.21203/rs.3.rs-3854490/v1. Res Sq. 2024. PMID: 38405932 Free PMC article. Preprint.
Post-pregnancy breast cancer often carries a poor prognosis, posing a major clinical challenge. ...Here, we report that cabergoline, a dopaminergic agonist, reduces the risk of breast cancer post-pregnancy in a Brca1/P53-deficient mouse model, with implications for …
Post-pregnancy breast cancer often carries a poor prognosis, posing a major clinical challenge. ...Here, we report that cabergoline, …
Mitochondrial dysfunction abrogates dietary lipid processing in enterocytes.
Moschandrea C, Kondylis V, Evangelakos I, Herholz M, Schneider F, Schmidt C, Yang M, Ehret S, Heine M, Jaeckstein MY, Szczepanowska K, Schwarzer R, Baumann L, Bock T, Nikitopoulou E, Brodesser S, Krüger M, Frezza C, Heeren J, Trifunovic A, Pasparakis M. Moschandrea C, et al. Among authors: frezza c. Nature. 2024 Jan;625(7994):385-392. doi: 10.1038/s41586-023-06857-0. Epub 2023 Dec 20. Nature. 2024. PMID: 38123683 Free PMC article.
Cancer Evolution: A Multifaceted Affair.
Ciriello G, Magnani L, Aitken SJ, Akkari L, Behjati S, Hanahan D, Landau DA, Lopez-Bigas N, Lupiáñez DG, Marine JC, Martin-Villalba A, Natoli G, Obenauf AC, Oricchio E, Scaffidi P, Sottoriva A, Swarbrick A, Tonon G, Vanharanta S, Zuber J. Ciriello G, et al. Among authors: vanharanta s. Cancer Discov. 2024 Jan 12;14(1):36-48. doi: 10.1158/2159-8290.CD-23-0530. Cancer Discov. 2024. PMID: 38047596 Free PMC article.
Cancer cells adapt and survive through the acquisition and selection of molecular modifications. This process defines cancer evolution. Building on a theoretical framework based on heritable genetic changes has provided insights into the mechanisms supporting can …
Cancer cells adapt and survive through the acquisition and selection of molecular modifications. This process defines cancer e …
The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells.
Koh GCC, Boushaki S, Zhao SJ, Pregnall AM, Sadiyah F, Badja C, Memari Y, Georgakopoulos-Soares I, Nik-Zainal S. Koh GCC, et al. Among authors: nik zainal s. Nat Genet. 2024 Jan;56(1):23-26. doi: 10.1038/s41588-023-01602-9. Epub 2023 Nov 30. Nat Genet. 2024. PMID: 38036782 Free PMC article.
690 results